The Settlement Facility has released information about the status of claims processing and payments through AUGUST 31, 2008, The information is summarized below:
Through AUGUST 31, 2008, the SF-DCT has received 75,242 Proof of Manufacturer claim forms in Classes 5, 6.1 and 6.2 (Dow Corning Breast Implant Claims). Of this number, 61,891 or 82.26% have acceptable proof of at least one Dow Corning breast implant. Of the 61,891 Dow Corning breast implant claimants with acceptable proof of manufacturer, almost 34% (one-third) or 20,988 women have been approved for a Rupture claim for their Dow Corning silicone gel breast implant.
CLASS 5, 6.1 AND 6.2 (EXCLUSIVE OF NOI PAYMENTS)
(DOW CORNING BREAST IMPLANT CLAIMS)
|
Claim Category
|
NUMBER OF CLAIMS PAID THROUGH JULY 31, 2008
|
PERCENTAGE OF CLAIMS APPROVED CLASS 5 | CLASS 6
|
TOTAL $$ PAID IN CATEGORY THROUGH JULY 31, 2008
|
| RUPTURE |
20,988 |
71% | 46% |
$408,441,274.17 |
| EXPLANT |
27,271 |
99% | 96% |
$132,335,614.69 |
| EXPLANT ASSISTANCE |
533 |
88% | 50% |
$2,645,091.10 |
| INCREASED EXPLANT (6.2 ONLY) |
53 |
N/A | 91% |
$159,000.00 |
| EXPEDITED RELEASE |
17,148 |
90% | 84% |
$32,096,163.90 |
| DISEASE OPTION 1 |
21,553 |
82% | 49% |
$320,096,985.56 |
| DISEASE OPTION 2 |
666 |
19% | 6% |
$84,925,482.47 |
| TOTAL |
88,212 |
N/A |
$980,699,611.89 |
Class 7 – Silicone Gel Material Claims
Approximately 14,632 claimants in Class 7 – Silicone Gel Material Claims – have been approved for either an Expedited Release Payment ($600) or a Disease Cash-Out Offer ($3,000). Total payments to date from the Class 7 Fund are approximately $20 million. The total fund is $57.5 million NPV. The Settlement Facility continues to review Proof of Manufacturer claims in Class 7 and expects to complete all Proof of Manufacturer reviews within the next few months and they will begin to process Class 7 disease claims after that. We are doing everything we can to urge the Settlement Facility to expedite the Class 7 Proof of Manufacturer reviews. As Proof of Manufacturer (POM) claims are approved, the Settlement Facility will send either the Class 7 Expedited Release Payment to eligible claimants who selected this option or a Disease Cash-Out Offer to claimants who selected the disease review. There are approximately 684 Proof of Manufacturer files pending review, and 1,236 Disease claims pending review, mostly in Disease Option 1.
There are a number of pending appeals before the Claims Administrator and Appeals Judge regarding the marshaling requirement for certain Class 7 claimants. No decision has been made on these appeals. We will update you on this as soon as the information is available.
CLASS 7
(SILICONE GEL MATERIAL CLAIMS)
| # Class 7 Forms Filed |
54,749 |
| Failed Prescreen – Ineligible Implant – & Deficiencies – Failed Marshalling |
37,379 |
| Foreign Gel Claims Approved & Paid $600 |
614 |
| Expedited Release Claims Approved & Paid $600 |
6,831 |
| # of Disease Cash-Out Offers of $3,000 |
7,187 |
| TOTAL PAYMENTS OR CASH-OUT OFFERS |
14,632 |
| TOTAL # of Claims Paid (excluding those who rejected the Cash-Out Offer) |
12,150 |
| TOTAL AMT PAID as of 06/30/2008 |
$20,321,900 |
Class 9 and 10 – Dow Corning Covered Other Products
Below is a chart showing the total number of Class 9 and 10 claims filed and paid to date:
CLASS 9, 10.1 AND 10.2
DCC "COVERED" OTHER PRODUCTS
|
CLAIM CATEGORY
|
NUMBER OF FORMS FILED
|
NUMBER OF CLAIMS REVIEWED
|
NUMBER OF CLAIMS APPROVED
|
# CLAIMS PAID 1ST PAYMENT
|
# CLAIMS PAID PREMIUM PAYMENT
|
PERCENTAGE OF CLAIMS APPROVED FOR 1ST PAYMENT
|
$ AMOUNT PAID 1ST PAYMENT
|
$ AMOUNT PAID PREMIUM PAYMENT
|
TOTAL PAID
|
| PROOF OF MANUFACTURER |
7226 |
7216 |
2619 |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
| EXPEDITED RELEASE |
3929 |
1576 |
1576 |
1969 |
N/A |
100% |
$1,870,595 |
N/A |
$1,870,595 |
| RUPTURE |
557 |
124 |
28 |
27 |
28 |
96% |
$131,000 |
$680,000 |
$811,000 |
| INFLAMMATORY FOREIGN BODY RESP. (TMJ, finger, wrist, toe, knee & hip) |
1745 |
713 |
410 |
385 |
377 |
94% |
$1,957,875 |
$8,564,775 |
$10,522,650 |
| IMPLANT FAILURE (TMJ, finger wrist, toe knee, hip & testicular) |
2321 |
831 |
110 |
102 |
102 |
93% |
$537,000 |
$2,394,350 |
$2,931,350 |
| TMJ ENHANCED |
1268 |
369 |
44 |
41 |
39 |
12% |
$520,500 |
$3,039,500 |
$3,560,000 |
| TOTALS |
17046 |
10832 |
4787 |
2524 |
549 |
TOTALS |
$5,016,970 |
$14,933,625 |
$19,950,595 |
NOI CLAIMS
CLASS 5, 6.1 AND 6.2
| |
TOTAL FORMS FILED |
FORMS FILED WITH POM |
ACCEPTABLE POM |
APPROVED |
COMPLETE |
# CLAIMS PAID |
TOTAL AMT PAID |
| RUPTURE |
1,865 |
1,829 |
1,226 |
872 |
1,211 |
853 |
$8,504,300 |
| MEDICALLY CONTRAINDICATED |
15 |
14 |
11 |
N/A |
8 |
0 |
N/A |
| EXPLANT |
1,395 |
1,379 |
1,157 |
992 |
1,142 |
969 |
$4,762,918 |
| INCREASED EXPLANT |
111 |
111 |
1 |
N/A |
N/A |
0 |
N/A |
| EAP |
309 |
303 |
239 |
19 |
26 |
17 |
$85,500 |
| TOTALS |
3,695 |
3,636 |
2,634 |
1,883 |
2,387 |
1,839 |
$13,352,218 |
© 2008 Claimants' Advisory Committee. All Rights Reserved.
|
